The US Food and Drug Administration (FDA) on Thursday expanded authorization of the Pfizer-BioNTech Covid booster to include 16- and 17-year-olds.
from NDTV News - Topstories https://ift.tt/3rRLYFo
https://ift.tt/eA8V8J https://www.ndtv.com
from NDTV News - Topstories https://ift.tt/3rRLYFo
https://ift.tt/eA8V8J https://www.ndtv.com
Post a Comment